JMPWA
COLL icon

JP Morgan Private Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,448
Closed -$259K – 1715
2020
Q3 		$259K Sell
12,448
-2,990
-19% -$54K ﹤0.01% 1421
2020
Q2 		$270K Buy
15,438
+148
+1% +$2.9K ﹤0.01% 1350
2020
Q1 		$250K Buy
15,290
+1,606
+12% +$33.1K ﹤0.01% 1196
2019
Q4 		$282K Buy
13,684
+366
+3% +$6.1K ﹤0.01% 1265
2019
Q3 		$153K Buy
+13,318
New +$152K ﹤0.01% 1370

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Private Wealth Advisors's COLL Position: Q4 2020 in Review

JP Morgan Private Wealth Advisors sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 12,448 shares — an estimated $259K sold.

JP Morgan Private Wealth Advisors first reported a position in COLL in Q3 2019 and held it in 5 quarters. The position peaked at $282K in Q4 2019. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • JP Morgan Private Wealth Advisors reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 12,448 Collegium Pharmaceutical shares in Q4 2020, an estimated $259K.
  • JP Morgan Private Wealth Advisors first reported a position in Collegium Pharmaceutical in Q3 2019 and held it in 5 quarters.
  • JP Morgan Private Wealth Advisors's Collegium Pharmaceutical position peaked at $282K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.